STOCK TITAN

Nutex Health declares $2-per-share special dividend

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Nutex Health Inc. declared its first cash dividend as a public company: a special cash dividend of $2.00 per share of common stock. It is payable December 14, 2026, to stockholders of record at the close of business November 30, 2026. The four independent directors unanimously approved the dividend; the company's three non-independent directors recused themselves.

Payment is conditioned on delivery of a customary certificate from the Chief Financial Officer to the independent directors before the payment date, and the board reserved the right to revoke or modify the dividend before then. Management anticipates recommending future regular quarterly cash dividends, but any declaration, timing and amount are subject to independent-director review and approval. The company gave no assurance that future dividends will be declared at similar levels or at all.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Special cash dividend per share $2.00 per share First cash dividend as a public company; payable December 14, 2026, to holders of record November 30, 2026
Record date November 30, 2026 Stockholders of record at close of business
Payment date December 14, 2026 Special cash dividend
special cash dividend financial
"declared a special cash dividend of $2.00 per share"
A special cash dividend is a one-time, extra cash payment a company gives to its shareholders in addition to its regular dividends, like a bonus check sent out when a business has more cash than usual. It matters to investors because it delivers immediate cash value, can signal that the company has strong short-term cash or limited opportunities to reinvest, and typically reduces the company’s cash reserves and may affect the stock price and tax treatment for recipients.
stockholders of record financial
"payable ... to stockholders of record as of the close of business"
Stockholders of record are the people or entities whose names appear on a company's official shareholder list on a specific cutoff date set by the company or its transfer agent; only those listed are entitled to receive dividends, vote at shareholder meetings, or participate in other corporate actions. Think of it like a guest list for an event: being on the list on the set day determines who gets the benefits and rights, so investors must own shares before the cutoff to qualify.
forward-looking statements regulatory
"constitute “forward-looking statements” within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is NUTX's special dividend, and when will it be paid?

Nutex Health declared a special cash dividend of $2.00 per share, payable December 14, 2026, to stockholders of record at the close of business November 30, 2026.

Who is eligible for the NUTX special dividend?

Stockholders of record at the close of business on November 30, 2026 are eligible for the special cash dividend, which is payable December 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001479681FALSE00014796812026-11-162026-11-16

UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549 
  
FORM 8-K 
  
CURRENT REPORT 
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
  
Date of Report (Date of earliest event reported): November 16, 2026 
  
NUTEX HEALTH INC.  
(Exact name of registrant as specified in its charter) 
  
Delaware 
001-41346
11-3363609 
(State or Other Jurisdiction 
of Incorporation)
(Commission File Number)
(I.R.S. Employer 
Identification No.)
  
1776 Yorktown St, Suite 700, Houston, Texas 77056 
(Address of principal executive offices) (zip code) 
  
(713) 660-0557 
(Registrant’s telephone number, including area code) 
  
N/A 
(Former name or former address, if changed since last report) 
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below): 
  
☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
☐ Precommencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
☐ Precommencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
  
Securities registered pursuant to Section 12(b) of the Act: 
  
Title of each class 
  
Trading Symbol(s) 
  
Name of each exchange on which registered 
Common Stock, $0.001 par value 
  
NUTX 
  
The NASDAQ Stock Market LLC 
Common Stock, $0.001 par value
NUTX
Nasdaq Texas, LLC
  
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 
Emerging growth company ☐ 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01 Other Events.
On November 16, 2026, the Board of Directors (the "Board") of Nutex Health Inc. (the "Company"), acting by the unanimous vote of its four independent directors, with the Company's three non-independent directors recused, declared a special cash dividend of $2.00 per share of the Company's common stock, par value $0.001 per share (the "Dividend"). The Dividend is payable on December 14, 2026 to stockholders of record as of the close of business on November 30, 2026.
Payment of the Dividend is conditioned upon delivery to the independent directors of a customary certificate of the Company's Chief Financial Officer prior to the payment date, and the Board has reserved the right to revoke or modify the Dividend prior to the payment date. Also, on November 17, 2026, the Company issued a press release announcing the action. The full text of this press release is included as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
 
Exhibit No.
Description of Exhibit
99.1
Press Release dated November 17, 2026
104
Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.




  
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
Date: November 17, 2026
NUTEX HEALTH INC. 
  
  
  
By: 
/s/ Jon C. Bates 
  
  
Jon C. Bates 
Chief Financial Officer 
  
  
 



Nutex Health Declares First Dividend as a Public Company
The Company’s Board of Directors Declares Special Cash Dividend of $2.00 Per Share
HOUSTON, Nov. 17, 2026 — Nutex Health Inc. (“Nutex Health” or the “Company”) (Nasdaq Global Market and Nasdaq Texas: NUTX), today announced that its Board of Directors (the “Board”), acting by unanimous approval of its independent directors, has declared a special cash dividend of $2.00 per share of the Company’s common stock, par value $0.001 per share. The dividend is the first cash dividend in the Company’s history as a public company.
The special dividend is payable on December 14, 2026 to stockholders of record as of the close of business on November 30, 2026. Payment of the dividend is conditioned upon delivery to the independent directors of a customary certificate of the Company’s Chief Financial Officer prior to the payment date, and the Board has reserved the right to revoke or modify the dividend prior to the payment date.
Management of Nutex Health anticipates recommending to the Board’s independent directors the payment of future regular quarterly cash dividends. However, the declaration, timing, and amount of any future dividends are subject to the review and approval of the Board’s independent directors. Whether to declare any future dividend, and the amount, record date and payment date of any such dividend, will be determined by the Board in its discretion and will depend on the Company’s financial condition, results of operations, capital requirements, contractual restrictions, compliance with applicable law and other factors the Board deems relevant. There can be no assurance that any future dividend will be declared at similar levels or at all paid.
“Declaring our first cash dividend as a public company reflects our commitment to delivering value to stockholders and our confidence in the strength and stability of our company,” stated Tom Vo, M.D., MBA, Chairman and CEO of Nutex Health. “Our strong cash flow and solid balance sheet allow us to return capital to stockholders while continuing to invest in long-term growth.”
About Nutex Health Inc.
Headquartered in Houston, Texas, and founded in 2011, Nutex Health Inc. (Nasdaq Global Market and Nasdaq Texas: NUTX) is a healthcare management and operations company with three divisions: a Hospital Division, Population Health Management Division, and Real Estate Division.
The Hospital Division owns, develops, and operates innovative healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 28 facilities in 12 states.
The Population Health Management Division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative, and other support services to our affiliated hospitals and physician groups.
The Real Estate Division comprises real estate entities along with activities related to the development and construction of hospital facilities. The real estate entities own the land and hospital buildings which are leased to our hospital entities.
Forward-Looking Statements
Certain statements and information included in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the payment of the special dividend and any future dividends. When used in this press release, the words or phrases “will,” “will likely result,” “expected to,” “expects,” “will continue,” “anticipated,” “anticipates,” “believe,” “may,” “estimate,” “projected,” “intend,” “goal,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, regulatory and litigation uncertainty under the No Surprises Act, lawsuits filed by health insurance providers against our third-party provider in the arbitration process, sales of a substantial amount of our common stock by our stockholders, our obligation to issue additional shares of our common stock to former doctor owners of under-construction hospitals, manipulative short seller reports, the impact of litigation and disputes, including pending earn-out disputes, securities class actions, derivative actions and class actions related to the recent cybersecurity incident, impacts of the recent and future cybersecurity incidents, our ability to successfully execute our growth strategy, including the timing of new hospital openings, economic conditions, dependence on management, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the



Company, newly developing technologies, the Company’s ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed under the heading “Risk Factors” in Part I, Item 1A of the Annual Report on Form 10-K for the year ended December 31, 2025 and in Part II, Item 1A of the subsequent Quarterly Reports on Form 10-Q for the periods ended March 31, 2026, June 30, 2026, and September 30, 2026, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company’s financial performance and could cause the Company’s actual results for future periods to differ materially from any opinions or statements expressed within this press release.
FOR ADDITIONAL INFORMATION:
Nutex Health, Inc.
Vivian Sanders – Director of Marketing
vsanders@nutexhealth.com


Filing Exhibits & Attachments

4 documents

Keep reading